Policy and Advocacy
Patients Redefining the Future of Health Care in Canada Summit
The annual Patients Redefining the Future of Health Care in Canada Summit is an initiative led by Save Your Skin Foundation in collaboration with the Psoriasis Canada (PsoCan) and an Indigenous volunteer from Kiyasiw Consulting. It provides opportunities for patients, caregivers, and patient advocates and representatives from diverse disease and disability groups to come together to discuss a shared vision for healthcare in Canada
Learn More: https://www.patientsummit.ca
To advance our goal of improving the lives of people affected by psoriasis and psoriatic arthritis in Canada, PsoCan is committed to providing input through government and other relevant consultations on issues that matter to our community. Thank you to everyone who helps to inform our submissions by responding to our surveys.
Patient Input Submissions
When a new drug for psoriasis or psoriatic arthritis comes to patients in Canada, it must be reviewed in the context of other drugs available for these diseases if the manufacturer wants it to be listed on a public drug formulary. The Quebec government has its own health technology assessment (HTA), done by the Institut national d’excellence en santé et en services sociaux (INESSS). All other government drug plans in Canada refer to the HTA done by Canada’s Drug Agency (CDA-AMC).
As part of these processes, patients are invited to share their experiences living with the disease, how helpful they find existing treatments, their treatment goals, and their experience with the new drug (if they have tried it) or their expectations of it (if they have not). Some provinces (BC, Ontario) have their own HTA processes that call for patient and caregiver input.
2026
Wynzora